Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, erasing what had been a fast start to 2025, according to HSBC.
Biotech startup funding dried up in second quarter, HSBC finds
Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, erasing what had been a fast start to 2025, according to HSBC.